Improving access to community-based pulmonary rehabilitation: 3R protocol for real-world settings with cost-benefit analysis

BMC Public Health

Volumn 19, Issue 1, 2019, Pages

  Marques, Alda ^a   Jácome, Cristina ^a,b   Rebelo, Patrícia ^a   Paixão, Cátia ^a   Oliveira, Ana ^a   Cruz, Joana ^c   Freitas, Célia ^a,b   Rua, Marília ^a,d   Loureiro, Helena ^a   Peguinho, Cristina ^a   Marques, Fábio ^e,i   Simões, Adriana ^f   Santos, Madalena ^g   Martins, Paula ^a   André, Alexandra ^h   De Francesco, Sílvia ^a,i   Martins, Vitória ^j   Brooks, Dina ^k,l   Simão, Paula ^m  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b University of Porto   (Portugal)

^c POLYTECHNIC INSTITUTE OF LEIRIA   (Portugal)

^d UNIVERSITY OF AVEIRO   (Portugal)

^e UNIVERSITY OF AVEIRO   (Portugal)

^f Câmara Municipal de Aveiro   (Portugal)

^g Câmara Municipal de Mira   (Portugal)

^h POLYTECHNIC INSTITUTE OF COIMBRA   (Portugal)

ⁱ UNIVERSITY OF AVEIRO   (Portugal)

^j Hospital Distrital da Figueira da Foz   (Portugal)

^k UNIVERSITY OF TORONTO   (Canada)

^l MCMASTER UNIVERSITY   (Canada)

^m Internal Medicine   (Portugal)

more..

Author keywords

Chronic respiratory diseases; Cost benefit; Education and psychosocial support; Exercise training; Primary healthcare

Indexed keywords

CLINICAL PROTOCOL; COMMUNITY CARE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE DELIVERY; HUMAN; LUNG DISEASE; ORGANIZATION AND MANAGEMENT; PROGRAM EVALUATION;

CLINICAL PROTOCOLS; COMMUNITY HEALTH SERVICES; COST-BENEFIT ANALYSIS; HEALTH SERVICES ACCESSIBILITY; HUMANS; LUNG DISEASES; PROGRAM EVALUATION;

EID: 85066618807     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-019-7045-1     Document Type: Article

References (109)

1. Forum of international respiratory societies. The global impact of respiratory disease. Sheffield: European Respiratory Society; 2017. p. 1-34.
2. WHO. The top 10 causes of death. Geneva: World Health Organization; 2018. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
3. ERS. The economic burden of lung disease in the European lung white book. Sheffield: European Respiratory Society; 2013. p. 16-27.
4. Arikan H, Savci S, Calik-Kutukcu E, Vardar-Yagli N, Saglam M, Inal-Ince D, et al. The relationship between cough-specific quality of life and abdominal muscle endurance, fatigue, and depression in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:1829-35.
5. Dowman LM, McDonald CF, Hill CJ, Lee AL, Barker K, Boote C, et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax. 2017;72(7):610-9.
6. Faisal A, Alghamdi BJ, Ciavaglia CE, Elbehairy AF, Webb KA, Ora J, et al. Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am J Respir Crit Care Med. 2016;193(3):299-309.
7. Jones LW, Eves ND, Haykowsky M, Freedland SJ, Mackey JR. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol. 2009;10(6):598-605.
8. Marcellis RG, Lenssen AF, Kleynen S, De Vries J, Drent M. Exercise capacity, muscle strength, and fatigue in sarcoidosis: a follow-up study. Lung. 2013;191(3):247-56.
9. Pastre J, Prevotat A, Tardif C, Langlois C, Duhamel A, Wallaert B. Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease. BMC Pulm Med. 2014;14:74.
10. Rochester CL, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA, et al. An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med. 2015;192(11):1373-86.
11. Spruit MA, Vercoulen JH, Sprangers MAG, Wouters EFM. Fatigue in COPD: an important yet ignored symptom. Lancet Respir Med. 2017;5(7):542-4.
12. Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J. 2009;33(1):99-106.
13. Vogiatzis I, Zakynthinos S. Factors limiting exercise tolerance in chronic lung diseases. Compr Physiol. 2012;2(3):1779-817.
14. Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J. 2014;44(6):1521-37.
15. Haselkorn T, Chen H, Miller DP, Fish JE, Peters SP, Weiss ST, et al. Asthma control and activity limitations: insights from the real-world evaluation of asthma control and treatment (REACT) study. Ann Allergy Asthma Immunol. 2010;104(6):471-7.
16. Johnson JL, Campbell AC, Bowers M, Nichol AM. Understanding the social consequences of chronic obstructive pulmonary disease: the effects of stigma and gender. Proc Am Thorac Soc. 2007;4(8):680-2.
17. Nakken N, Janssen DJ, van den Bogaart EH, Vercoulen JH, Wouters EF, Spruit MA. An observational, longitudinal study on the home environment of people with chronic obstructive pulmonary disease: the research protocol of the home sweet home study. BMJ Open. 2014;4(11):e006098.
18. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390-413.
19. Swigris JJ, Stewart AL, Gould MK, Wilson SR. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes. 2005;3:61.
20. Cruz J, Marques A, Figueiredo D. Impacts of COPD on family carers and supportive interventions: a narrative review. Health Soc Care Community. 2017;25(1):11-25.
21. Shah RJ, Collard HR, Morisset J. Burden, resilience and coping in caregivers of patients with interstitial lung disease. Heart Lung. 2018;47(3):264-8.
22. Bragadottir GH, Halldorsdottir BS, Ingadottir TS, Jonsdottir H. Patients and families realising their future with chronic obstructive pulmonary disease-a qualitative study. J Clin Nurs. 2018;27(1-2):57-64.
23. Farquhar M. Assessing carer needs in chronic obstructive pulmonary disease. Chronic Respir Dis. 2018;15(1):26-35.
24. Nakken N, Janssen DJ, van den Bogaart EH, Wouters EF, Franssen FM, Vercoulen JH, et al. Informal caregivers of patients with COPD: home sweet home? Eur Respir Rev. 2015;24(137):498-504.
25. Tan JY, Molassiotis A, Lloyd-Williams M, Yorke J. Burden, emotional distress and quality of life among informal caregivers of lung cancer patients: an exploratory study. Eur J Cancer Care. 2018;27(1):1-11.
26. Robinson K, Lucas E, van den Dolder P, Halcomb E. Living with chronic obstructive pulmonary disease: the stories of frequent attenders to the emergency department. J Clin Nurs. 2018;27(1-2):48-56.
27. Marques A, Jacome C, Cruz J, Gabriel R, Brooks D, Figueiredo D. Family-based psychosocial support and education as part of pulmonary rehabilitation in COPD: a randomized controlled trial. Chest. 2015;147(3):662-72.
28. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-64.
29. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014;10:Cd006322.
30. Gomes-Neto M, Silva CM, Ezequiel D, Conceicao CS, Saquetto M, Machado AS. Impact of pulmonary rehabilitation on exercise tolerance and quality of life in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. J Cardiopulm Rehabil Prev. 2018;38(5):273-8.
31. Hoffman M, Chaves G, Ribeiro-Samora GA, Britto RR, Parreira VF. Effects of pulmonary rehabilitation in lung transplant candidates: a systematic review. BMJ Open. 2017;7(2):e013445.
32. Keusch S, Turk A, Saxer S, Ehlken N, Grunig E, Ulrich S, et al. Rehabilitation in patients with pulmonary arterial hypertension. Swiss Med Wkly. 2017;147:w14462.
33. Lee AL, Hill CJ, McDonald CF, Holland AE. Pulmonary rehabilitation in individuals with non-cystic fibrosis bronchiectasis: a systematic review. Arch Phys Med Rehabil. 2017;98(4):774-82.e1.
34. Liu XL, Tan JY, Wang T, Zhang Q, Zhang M, Yao LQ, et al. Effectiveness of home-based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials. Rehabil Nurs. 2014;39(1):36-59.
35. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:Cd003793.
36. Neves LF, Reis MH, Goncalves TR. Home or community-based pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Cad Saude Publica. 2016;32(6):1-25.
37. Rivas-Perez H, Nana-Sinkam P. Integrating pulmonary rehabilitation into the multidisciplinary management of lung cancer: a review. Respir Med. 2015;109(4):437-42.
38. Vogiatzis I, Rochester CL, Spruit MA, Troosters T, Clini EM. Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement. Eur Respir J. 2016;47(5):1336-41.
39. ERS. Pulmonary rehabilitation in the in the European lung white book. Sheffield: European Respiratory Society; 2013. p. 340-7.
40. Jenkins S, Hill K, Cecins NM. State of the art: how to set up a pulmonary rehabilitation program. Respirology (Carlton, Vic). 2010;15(8):1157-73.
41. Souto-Miranda S, Marques A. Triangulated perspectives on outcomes of pulmonary rehabilitation in patients with COPD: a qualitative study to inform a core outcome set. Clin Rehabil. 2019;33(4):805-14.
42. Marques A, Gabriel R, Jacome C, Cruz J, Brooks D, Figueiredo D. Development of a family-based pulmonary rehabilitation programme: an exploratory study. Disabil Rehabil. 2015;37(15):1340-6.
43. GINA. Global Strategy for asthma management and prevention update 2018. Global initiative for asthma. 2018.
44. GOLD. Global Strategy for Diagnosis, Management, and prevention of chronic obstructive pulmonary disease 2019 report, The Global Initiative for Chronic Obstructive Lung Disease; 2019. p. 1-155.
45. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-51.
46. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-38.
47. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med. 1991;85(Suppl B):25-31 discussion 3-7.
48. group W. The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med (1982). 1998;46(12):1569-85.
49. Vaz Serra A, Canavarro MC, Simões MR, Pereira M, Gameiro S, Quartilho MJ, et al. Estudos psicométricos do instrumento de avaliação da qualidade de vida da Organização Mundial de Saúde (WHOQOL-Bref) para Português de Portugal. Psiquiatria Clínica. 2006;27(1):41-9.
50. Kumar S, Williams AC, Sandy JR. How do we evaluate the economics of health care? Eur J Orthod. 2006;28(6):513-9.
51. Crisafulli E, Clini EM. Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med. 2010;5(3):202-10.
52. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383-92.
53. Antoniu SA, Ungureanu D. Measuring fatigue as a symptom in COPD: from descriptors and questionnaires to the importance of the problem. Chron Respir Dis. 2015;12(3):179-88.
54. Webster K, Cella D, Yost K. The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79.
55. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax. 2003;58(4):339-43.
56. Crawford B, Monz B, Hohlfeld J, Roche N, Rubin B, Magnussen H, et al. Development and validation of a cough and sputum assessment questionnaire. Respir Med. 2008;102(11):1545-55.
57. George F. Diagnóstico e Tratamento da Doença Pulmonar Obstrutiva Crónica. Direção Geral da Saúde. 2013;028:1-15.
58. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648-54.
59. Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M. Validation study of a Portuguese version of the hospital anxiety and depression scale. Psychol Health Med. 2007;12(2):225-35 quiz 35-7.
60. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70.
61. Curral R, Dourado F, Roma Torres A, Barros H, Palha A, Almeida L. Coesão e adaptabilidade familiares numa amostra portuguesa: estudo com o Faces III. Psiquiatria Clínica. 1999;20(3):213-7.
62. Olson D. FACES IV and the Circumplex model: validation study. J Marital Fam Ther. 2011;37(1):64-80.
63. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther. 1996;76(3):248-59.
64. Garvey C, Bayles MP, Hamm LF, Hill K, Holland A, Limberg TM, et al. Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: review of selected guidelines: an official statement from the american association of cardiovascular and pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2016;36(2):75-83.
65. Charususin N, Gosselink R, Decramer M, Demeyer H, McConnell A, Saey D, et al. Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD. Thorax. 2018;73(10):942-50.
66. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428-46.
67. Vaidya T, Chambellan A, de Bisschop C. Sit-to-stand tests for COPD: a literature review. Respir Med. 2017;128:70-7.
68. Padgett PK, Jacobs JV, Kasser SL. Is the BESTest at its best? A suggested brief version based on interrater reliability, validity, internal consistency, and theoretical construct. Phys Ther. 2012;92(9):1197-207.
69. Chan R, Newton M, Nosaka K. Measurement of biceps brachii muscle cross-sectional area bu extended-field-of view ultrasound imaging techniques. Kinesiologia Slovenica. 2012;18(2):36-44.
70. Seymour JM, Ward K, Sidhu PS, Puthucheary Z, Steier J, Jolley CJ, et al. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax. 2009;64(5):418-23.
71. Ye X, Wang M, Xiao H. Echo intensity of the rectus femoris in stable COPD patients. Int J Chron Obstruct Pulmon Dis. 2017;12:3007-15.
72. Smargiassi A, Inchingolo R, Soldati G, Copetti R, Marchetti G, Zanforlin A, et al. The role of chest ultrasonography in the management of respiratory diseases: document II. Multidiscip Respir Med. 2013;8(1):55.
73. Testa A, Soldati G, Giannuzzi R, Berardi S, Portale G, Gentiloni Silveri N. Ultrasound M-mode assessment of diaphragmatic kinetics by anterior transverse scanning in healthy subjects. Ultrasound Med Biol. 2011;37(1):44-52.
74. Zanforlin A, Smargiassi A, Inchingolo R, Valente S, Ramazzina E. Ultrasound in obstructive lung diseases: the effect of airway obstruction on diaphragm kinetics. A short pictorial essay. J Ultrasound. 2015;18(4):379-84.
75. Kamper SJ, Maher CG, Mackay G. Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther. 2009;17(3):163-70.
76. ATS/ERS. American Thoracic Society/European Respiratory Society statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518-624.
77. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81.
78. Hill K, Jenkins SC, Cecins N, Philippe DL, Hillman DR, Eastwood PR. Estimating maximum work rate during incremental cycle ergometry testing from six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2008;89(9):1782-7.
79. ACSM. Guidelines for exercise testing and prescription. 10th ed. Philadelphia: Lippincott Williams and Wilkins; 2017.
80. Beauchamp MK, Janaudis-Ferreira T, Parreira V, Romano JM, Woon L, Goldstein RS, et al. A randomized controlled trial of balance training during pulmonary rehabilitation for individuals with COPD. Chest. 2013;144(6):1803-10.
81. (Lab3R) LdIeRR. Plataforma de Reabilitação Respiratória em Rede. 2018. http://3rwebuapt/.
82. Holland AE, Watson A, Glaspole I. Comprehensive pulmonary rehabilitation for interstitial lung disease: a consensus approach to identify core education topics. Patient Educ Couns. 2019;102(6):1125-30.
83. Stoilkova A, Janssen DJ, Wouters EF. Educational programmes in COPD management interventions: a systematic review. Respir Med. 2013;107(11):1637-50.
84. Roberts NJ, Kidd L, Kirkwood K, Cross J, Partridge MR. A systematic review of the content and delivery of education in pulmonary rehabilitation programmes. Respir Med. 2018;145:161-81.
85. WHO. Global Strategy on Diet, Physical Activity and Health World Health Organization; 2019.
86. Cruz J, Brooks D, Marques A. Walk2Bactive: a randomised controlled trial of a physical activity-focused behavioural intervention beyond pulmonary rehabilitation in chronic obstructive pulmonary disease. Chron Respir Dis. 2016;13(1):57-66.
87. Mendoza L, Horta P, Espinoza J, Aguilera M, Balmaceda N, Castro A, et al. Pedometers to enhance physical activity in COPD: a randomised controlled trial. Eur Respir J. 2015;45(2):347-54.
88. Tudor-Locke C, Craig CL, Aoyagi Y, Bell RC, Croteau KA, De Bourdeaudhuij I, et al. How many steps/day are enough? For older adults and special populations. Int J Behav Nutr Phys Act. 2011;8(1):1.
89. Fischer MJ, Scharloo M, Abbink JJ, van 't Hul AJ, van Ranst D, Rudolphus A, et al. Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med. 2009;103(10):1564-71.
90. Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J. 2006;27(4):788-94.
91. Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012;24(3):69-71.
92. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (London, England). 1986;1(8476):307-10.
93. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74.
94. Ma Y, Mazumdar M, Memtsoudis SG. Beyond repeated-measures analysis of variance: advanced statistical methods for the analysis of longitudinal data in anesthesia research. Reg Anesth Pain Med. 2012;37(1):99-105.
95. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102-9.
96. Angst F, Aeschlimann A, Angst J. The minimal clinically important difference raised the significance of outcome effects above the statistical level, with methodological implications for future studies. J Clin Epidemiol. 2017;82:128-36.
97. Doi SA, Thalib L. A quality-effects model for meta-analysis. Epidemiol (Cambridge, Mass). 2008;19(1):94-100.
98. Alma H, de Jong C, Tsiligianni I, Sanderman R, Kocks J, van der Molen T. Clinically relevant differences in COPD health status: systematic review and triangulation. Eur Respir J. 2018;52(3):1-38.
99. Culyer AJ, Chalkidou K. Economic evaluation for health investments En route to universal health coverage: cost-benefit analysis or cost-effectiveness analysis? Value Health. 2019;22(1):99-103.
100. Russell LB, Sinha A. Strengthening cost-effectiveness analysis for public health policy. Am J Prev Med. 2016;50(5 Suppl 1):S6-s12.
101. Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ. 2007;16(3):307-17.
102. Zwerink M, Effing T, Kerstjens HA, van der Valk P, Brusse-Keizer M, Zielhuis G, et al. Cost-effectiveness of a community-based exercise Programme in COPD self-management. Copd. 2016;13(2):214-23.
103. Muennig P, Bounthavong M. Cost-effectiveness analysis in health: a practical approach. 3rd ed. San Francisco: Jossey-Bass; 2016.
104. Towers I, Spencer A, Brazier J. Healthy year equivalents versus quality-adjusted life years: the debate continues. Expert Rev Pharmacoecon Outcomes Res. 2005;5(3):245-54.
105. McIntosh E, Clarke P, Frew E, Jordan L. Applied methods of cost-benefit analysis in health care. Oxford: Oxford University Press; 2010.
106. De Gruyter E, Ford G, Stavreski B. Economic and social impact of increasing uptake of cardiac rehabilitation services - a cost benefit analysis. Heart Lung Circ. 2016;25(2):175-83.
107. Huter K, Kocot E, Kissimova-Skarbek K, Dubas-Jakobczyk K, Rothgang H. Economic evaluation of health promotion for older people-methodological problems and challenges. BMC Health Serv Res. 2016;16(Suppl 5):328.
108. Cecins N, Landers H, Jenkins S. Community-based pulmonary rehabilitation in a non-healthcare facility is feasible and effective. Chron Respir Dis. 2017;14(1):3-10.
109. Crimi C, Heffler E, Augelletti T, Campisi R, Noto A, Vancheri C, et al. Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:3131-9.